Shandong Jincheng Pharmaceutical Group Co., Ltd / Fundamentals

    Income statement

    Net revenue
    €353.98M
    Cost of goods sold
    €219.42M
    Gross profit
    €134.56M
    SG&A expenses
    €86.32M
    R&D expenses
    €19.35M
    EBITDA
    €30.77M
    D&A
    €10.09M
    EBIT
    €19.81M
    Interest expenses
    €1.72M
    EBT
    €19.54M
    Tax expenses
    €6.01M
    Net income
    €13.04M

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    €20.32M
    Changes in working capital
    €0.00
    Operating cash flow
    €26.93M
    Capex
    €11.85M
    Other investing cash flow
    €1.48M
    Net investing cash flow
    -€10.42M
    Total cash dividends paid
    -€19.77M
    Issuance of common stock
    €0.00
    Debt repayment
    -€27.74M
    Other financing cash flow
    -€2.17M
    Net financing cash flow
    -€49.67M
    Foreign exchange effects
    €469.67K
    Net change in cash
    -€32.74M
    Cash at end of period
    €82.59M
    Free cash flow
    €38.78M

    Balance sheet

    Cash and cash equivalents
    €89.70M
    Cash and short-term investments
    €89.70M
    Total receivables
    €72.90M
    Inventory
    €72.08M
    Other current assets
    €3.89M
    Total current assets
    €238.57M
    Property, plant & equipment
    €269.52M
    Goodwill
    €0.00
    Intangible assets
    €89.40M
    Long-term investments
    €0.00
    Other non-current assets
    €24.85M
    Total non-current assets
    €390.05M
    Total assets
    €628.62M
    Accounts payable
    €64.52M
    Short-term debt
    €13.57M
    Other current liabilities
    €49.70M
    Total current liabilities
    €130.09M
    Long-term debt
    €30.02M
    Deferred tax liabilities
    €14.04M
    Other non-current liabilities
    €241.63K
    Total non-current liabilities
    €50.65M
    Total liabilities
    €180.74M
    Common stock
    €45.67M
    Retained earnings
    €99.28M
    Other equity
    €0.00
    Total equity
    €447.88M
    Total liabilities and shareholders' equity
    €628.62M

    Company information

    Market capitalization
    €768.18M
    Employees
    3.7K
    Enterprise Value
    €5.88B

    Company ratios

    Gross margin
    38.0%
    EBITDA margin
    8.7%
    EBIT margin
    5.6%
    EBT margin
    5.5%
    Net margin
    3.7%
    ROE
    2.9%
    ROA
    2.1%
    Asset turnover
    56.3%
    FCF margin
    4.3%
    FCF yield
    2.0%
    Efficiency ratio
    91.3%
    Net sales per employee
    €96.79K
    Net income per employee
    €3.56K

    Notifications